Clinique, a brand under the Estée Lauder Companies, has launched a new skincare line in China featuring recombinant PDRN as its core ingredient. This move signifies the brand's expansion into the rapidly growing PDRN skincare market and its continued emphasis on scientific skincare and its connection to medical aesthetics. The introduction of this product aligns with a broader trend of high-end beauty brands integrating medical-grade ingredients and technologies into their daily skincare offerings to cater to consumers seeking long-term skin management and post-medical aesthetic treatment care. AI
IMPACT This product launch reflects a trend of beauty brands incorporating advanced ingredients, potentially influenced by AI-driven research in material science and personalized skincare.
RANK_REASON Product launch by a beauty brand incorporating a medical-grade ingredient.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
